How long does h&r block keep tax records

1. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–5204. [PMC free article] [PubMed] [Google Scholar]

2. Sakurai K, Suda H, Ido Y, Takeichi T, Okuda A, Hasuda K, Hattori M. Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy. World J Gastroenterol. 2017;23:668–675. [PMC free article] [PubMed] [Google Scholar]

3. Lin LC, Hsu TH, Huang KW, Tam KW. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. World J Gastroenterol. 2016;22:5445–5453. [PMC free article] [PubMed] [Google Scholar]

4. Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015;5:164–174. [PMC free article] [PubMed] [Google Scholar]

5. Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: Past, present and future. World J Gastrointest Pathophysiol. 2014;5:392–399. [PMC free article] [PubMed] [Google Scholar]

6. Reshetniak VI, Dudik TV, Solov’eva NA, Zhukhovitskiĭ VG, Il’chenko AA, Kaprel’iants AS. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin] Antibiot Khimioter. 2002;47:16–19. [PubMed] [Google Scholar]

7. Loginov AS, Reshetniak VI, Mukamolova GV, Fedukova NG, Il’chenko AA, Dudik TV, Kaprel’iants AS. [The possibility of Helicobacter pylori being present in the resting state in the gastric mucosa of peptic acid patients after treatment] Ter Arkh. 1999;71:13–16. [PubMed] [Google Scholar]

8. Loginov AS, Reshetnyak VI, Dudik TV, Vostroknutova GN, Il’chenko AA, Kaprel’yants AS. Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication. Bull Exp Biol Med. 2001;132:802–806. [PubMed] [Google Scholar]

9. Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol. 2014;20:12781–12808. [PMC free article] [PubMed] [Google Scholar]

10. Fernandes YC, Bonatto Gda R, Bonatto MW. Recurrence rate of Helicobacter pylori in patients with peptic ulcer five years or more after successful eradication. Arq Gastroenterol. 2016;53:152–155. [PubMed] [Google Scholar]

11. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1315. [PubMed] [Google Scholar]

12. Steensma DP, Kyle RA, Shampo MA. J. Robin Warren: Helicobacter pylori and peptic ulcer. Mayo Clin Proc. 2016;91:e129–e130. [PubMed] [Google Scholar]

13. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863–1873. [PMC free article] [PubMed] [Google Scholar]

14. Siddique I, Al-Qabandi A, Al-Ali J, Alazmi W, Memon A, Mustafa AS, Junaid TA. Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East. Gut Pathog. 2014;6:41. [PMC free article] [PubMed] [Google Scholar]

15. Chen YL, Mo XQ, Huang GR, Huang YQ, Xiao J, Zhao LJ, Wei HY, Liang Q. Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases. World J Gastroenterol. 2016;22:9718–9726. [PMC free article] [PubMed] [Google Scholar]

16. Kidd M, Modlin IM. A century of Helicobacter pylori: paradigms lost-paradigms regained. Digestion. 1998;59:1–15. [PubMed] [Google Scholar]

17. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–1186. [PubMed] [Google Scholar]

18. van Amsterdam K, van Vliet AH, Kusters JG, van der Ende A. Of microbe and man: determinants of Helicobacter pylori-related diseases. FEMS Microbiol Rev. 2006;30:131–156. [PubMed] [Google Scholar]

19. Cellini L, Grande R, Di Campli E, Di Bartolomeo S, Di Giulio M, Traini T, Trubiani O. Characterization of an Helicobacter pylori environmental strain. J Appl Microbiol. 2008;105:761–769. [PubMed] [Google Scholar]

20. Rudnicka K, Graczykowski M, Tenderenda M, Chmiela M. [Helicobacter pylori morphological forms and their potential role in the transmission of infection] Postepy Hig Med Dosw (Online) 2014;68:219–229. [PubMed] [Google Scholar]

21. Mohammed SA. Prevalence of Helicobacter pylori among patients with different gastrointestinal disorders in Saudi Arabia. Med J Indones. 2017;25:214. [Google Scholar]

22. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22:283–297. [PubMed] [Google Scholar]

23. Perry S, de la Luz Sanchez M, Yang S, Haggerty TD, Hurst P, Perez-Perez G, Parsonnet J. Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis. 2006;12:1701–1708. [PMC free article] [PubMed] [Google Scholar]

24. Júnior R, Fernandes AB, Santos FSD, Silva JHG, Loiola RPD, Silva JG, Pereira JO. Soroprevalência da infecção por Helicobacter pylori em uma amostra rural do Estado do Amazonas, Brasil Rev Pan-Amazônica de Saúde 2012; 3: 33-36. [Google Scholar]

25. Fonseca FM, Etchebehere RM, Oliveira AG. Helicobacter pylori infection in patients undergoing upper endoscopy at University Hospital in Uberaba, Minas Gerais, Brazil. JMPHC. 2013;4:33–35. [Google Scholar]

26. Oliveira JG, Ferreira CH, Camerin AC, Rota CA, Meurer L, Silveira TR. Prevalence of infection with cagA-positive Helicobacter pylori strains among children and adolescents in southern Brazil. Arq Gastroenterol. 2014;51:180–185. [PubMed] [Google Scholar]

27. Bor S, Kitapcioglu G, Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol. 2017;23:525–532. [PMC free article] [PubMed] [Google Scholar]

28. Wijetunge S, Kotakadeniya R, Noordeen F, Buharideen SM, Samarasinghe B, Dharmapala A, Galketiya KB. Prevalence of Helicobacter pylori in benign gastric ulcers in a cohort of Sri Lankan patients. Ceylon Med J. 2015;60:152–154. [PubMed] [Google Scholar]

29. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1–5. [PubMed] [Google Scholar]

30. German SV, Zykova IE, Modestova AV, Yermakov NV. [Prevalence of infection Helicobacter pylori in Moscow population] Russian J Gastroenterol, Hepatol, Coloproctol. 2010;20:25–30. [Google Scholar]

31. Das JC, Paul N. Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J Pediatr. 2007;74:287–290. [PubMed] [Google Scholar]

32. Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006;19:597–613. [PMC free article] [PubMed] [Google Scholar]

33. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990;335:1233–1235. [PubMed] [Google Scholar]

34. Blaser MJ, Parsonnet J. Parasitism by the “slow” bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest. 1994;94:4–8. [PMC free article] [PubMed] [Google Scholar]

35. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest. 1997;100:759–762. [PMC free article] [PubMed] [Google Scholar]

36. Axon A. Helicobacter pylori is not a commensal. Curr Opin Gastroenterol. 1999;15:1–4. [Google Scholar]

37. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis. 1999;179:1523–1530. [PubMed] [Google Scholar]

39. Ierardi E, Goni E, Losurdo G, Di Mario F. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2014;19 Suppl 1:27–31. [PubMed] [Google Scholar]

40. Alzahrani S, Lina TT, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Effect of Helicobacter pylori on gastric epithelial cells. World J Gastroenterol. 2014;20:12767–12780. [PMC free article] [PubMed] [Google Scholar]

41. da Costa DM, Pereira Edos S, Rabenhorst SH. What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases. World J Gastroenterol. 2015;21:10563–10572. [PMC free article] [PubMed] [Google Scholar]

42. Kim A, Servetas SL, Kang J, Kim J, Jang S, Cha HJ, Lee WJ, Kim J, Romero-Gallo J, Peek RM Jr, Merrell DS, Cha JH. Helicobacter pylori bab Paralog Distribution and Association with cagA, vacA, and homA/B genotypes in American and South Korean clinical isolates. PLoS One. 2015;10:e0137078. [PMC free article] [PubMed] [Google Scholar]

43. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990;161:626–633. [PubMed] [Google Scholar]

44. Shkitin VA, Shpirna AI, Starovoitov GN. [Role of Helicobacter pylori in human pathology] Klinicheskaya Mikrobiologiya i Antimikrobnaya Khimioterapiya. 2002;4:128–145. [Google Scholar]

45. Yamaoka Y. Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract. 2012;2012:371503. [PMC free article] [PubMed] [Google Scholar]

46. Liu J, He C, Chen M, Wang Z, Xing C, Yuan Y. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis. 2013;13:555. [PMC free article] [PubMed] [Google Scholar]

47. Owen RJ. Helicobacter-species classification and identification. Br Med Bull. 1998;54:17–30. [PubMed] [Google Scholar]

48. Whary MT, Fox JG. Natural and experimental Helicobacter infections. Comp Med. 2004;54:128–158. [PubMed] [Google Scholar]

49. Mateos-Muñoz B, Pérez-de-la-Serna J, Ruiz-de-León A, Serrano-Falcón B, Casabona-Francés S, Velasco-Cerrudo A, Rey-Díaz-Rubio E. Enterohepatic Helicobacter other than Helicobacter pylori. Rev Esp Enferm Dig. 2013;105:477–484. [PubMed] [Google Scholar]

50. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest. 2001;107:767–773. [PMC free article] [PubMed] [Google Scholar]

51. Bardakhch’ian EA, Lomov SIu, Kharlanova NG, Kamneva NV. [Role of Helicobacter pylori in different extragastroduodenal diseases] Eksp Klin Gastroenterol. 2005;(3):20–27. [PubMed] [Google Scholar]

52. Chumpitaz Conde J, Gutiérrez Manay J, Córdova Acosta R, Sánchez Medina M, Vásquez Valverde N, Rivadeira Malaga C, Beteta Del Carpio O, Solano Mendoza L, Marocho Chahuayo L, Pareja Cuadros E, et al. [Isolation of helicobacter pylori in dental plaque in patients with gastritis at “Angamos” clinic] Rev Gastroenterol Peru. 2006;26:373–376. [PubMed] [Google Scholar]

53. Dubois A. Intracellular Helicobacter pylori and gastric carcinogenesis: an “old” frontier worth revisiting. Gastroenterology. 2007;132:1177–1180. [PMC free article] [PubMed] [Google Scholar]

54. O'Rourke J, Bode G. Morphology and ultrastructure (Chapter 6). In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: physiology and genetics. Washington (DC): ASM Press. 2001 Available from: https://www.ncbi.nlm.nih.gov/books/NBK2452/ [Google Scholar]

55. Goodwin CS, McCulloch RK, Armstrong JA, Wee SH. Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol. 1985;19:257–267. [PubMed] [Google Scholar]

56. Jones DM, Curry A, Fox AJ. An ultrastructural study of the gastric campylobacter-like organism ‘Campylobacter pyloridis’ J Gen Microbiol. 1985;131:2335–2341. [PubMed] [Google Scholar]

57. Qin Z, Lin WT, Zhu S, Franco AT, Liu J. Imaging the motility and chemotaxis machineries in Helicobacter pylori by cryo-electron tomography. J Bacteriol. 2016 Epub ahead of print. [PMC free article] [PubMed] [Google Scholar]

58. Sidebotham RL, Baron JH. Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet. 1990;335:193–195. [PubMed] [Google Scholar]

59. Sasaki K, Tajiri Y, Sata M, Fujii Y, Matsubara F, Zhao M, Shimizu S, Toyonaga A, Tanikawa K. Helicobacter pylori in the natural environment. Scand J Infect Dis. 1999;31:275–279. [PubMed] [Google Scholar]

60. Talebi Bezmin Abadi A, Perez-Perez G. Role of dupA in virulence of Helicobacter pylori. World J Gastroenterol. 2016;22:10118–10123. [PMC free article] [PubMed] [Google Scholar]

61. Makarenko EV, Voropaeva AV, Matveyenko ME. [The effect of Helicobacter pylori genotypes on morphological parameters of the gastric mucosa in patients with duodenal ulcer and chronic gastritis] Vestnik VGMU. 2009;8:88–96. [Google Scholar]

62. Azevedo NF, Almeida C, Cerqueira L, Dias S, Keevil CW, Vieira MJ. Coccoid form of Helicobacter pylori as a morphological manifestation of cell adaptation to the environment. Appl Environ Microbiol. 2007;73:3423–3427. [PMC free article] [PubMed] [Google Scholar]

63. Kaprelyants AS, Gottschal JC, Kell DB. Dormancy in non-sporulating bacteria. FEMS Microbiol Rev. 1993;10:271–285. [PubMed] [Google Scholar]

64. Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect. 1993;111:483–490. [PMC free article] [PubMed] [Google Scholar]

65. Faghri J, Poursina F, Moghim S, Zarkesh Esfahani H, Nasr Esfahani B, Fazeli H, Mirzaei N, Jamshidian A, Ghasemian Safaei H. Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori. Jundishapur J Microbiol. 2014;7:e8704. [PMC free article] [PubMed] [Google Scholar]

66. Saito N, Konishi K, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M. Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability. J Infect. 2003;46:49–55. [PubMed] [Google Scholar]

67. Mouery K, Rader BA, Gaynor EC, Guillemin K. The stringent response is required for Helicobacter pylori survival of stationary phase, exposure to acid, and aerobic shock. J Bacteriol. 2006;188:5494–5500. [PMC free article] [PubMed] [Google Scholar]

68. Williams CL. Helicobacter pylori: bacteriology and laboratory diagnosis. J Infect. 1997;34:1–5. [PubMed] [Google Scholar]

69. Khomeriki SG, Morozov IA. The role of coccoid forms of Helicobacter pylori in pathogenetic mechanisms and persistence of Helicobacter infection. Russian J Gastroenterol, Hepatol, Coloproctol. 2001;11 Suppl 13:99–102. [Google Scholar]

70. Anuchin AM, Mulyukin AL, Suzina NE, Duda VI, El-Registan GI, Kaprelyants AS. Dormant forms of Mycobacterium smegmatis with distinct morphology. Microbiology. 2009;155:1071–1079. [PubMed] [Google Scholar]

71. Kudykina YK, Shleeva MO, Artsabanov VY, Suzina NE, Kaprel’iants AS. [Generation of dormant forms by Mycobacterium smegmatis in the poststationary phase during gradual acidification of the medium] Mikrobiologiia. 2011;80:625–636. [PubMed] [Google Scholar]

72. Kell DB, Kaprelyants AS, Weichart DH, Harwood CR, Barer MR. Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie Van Leeuwenhoek. 1998;73:169–187. [PubMed] [Google Scholar]

73. Tutelyan AV, Gaponov AM, Pisarev VM, El-Registan GI. [Microbial dormancy and prevention of healthcare-associated infections] Ter Arkh. 2015;87:103–108. [PubMed] [Google Scholar]

74. Sarem M, Corti R. [Role of Helicobacter pylori coccoid forms in infection and recrudescence] Gastroenterol Hepatol. 2016;39:28–35. [PubMed] [Google Scholar]

75. West AP, Millar MR, Tompkins DS. Survival of Helicobacter pylori in water and saline. J Clin Pathol. 1990;43:609. [PMC free article] [PubMed] [Google Scholar]

76. Catrenich CE, Makin KM. Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gastroenterol Suppl. 1991;181:58–64. [PubMed] [Google Scholar]

77. Moshkowitz M, Gorea A, Arber N, Konikoff F, Berger S, Gilat T. Morphological transformation of Helicobacter pylori during prolonged incubation: association with decreased acid resistance. J Clin Pathol. 1994;47:172–174. [PMC free article] [PubMed] [Google Scholar]

78. Benaissa M, Babin P, Quellard N, Pezennec L, Cenatiempo Y, Fauchère JL. Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infect Immun. 1996;64:2331–2335. [PMC free article] [PubMed] [Google Scholar]

79. Faizullina RA, Abdullina EV. Factors of pathogenicity and virulence of Helicobacter pylori in the development of Helicobacter-associated gastroduodenal pathology. Prakticheskaya Meditsina. 2011;1:74–78. [Google Scholar]

80. Nilius M, Ströhle A, Bode G, Malfertheiner P. Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity. Zentralbl Bakteriol. 1993;280:259–272. [PubMed] [Google Scholar]

81. Can F, Karahan C, Dolapci I, Demirbilek M, Tekeli A, Arslan H. Urease activity and urea gene sequencing of coccoid forms of H. pylori induced by different factors. Curr Microbiol. 2008;56:150–155. [PubMed] [Google Scholar]

82. Hua J, Ho B. Is the coccoid form of Helicobacter pylori viable? Microbios. 1996;87:103–112. [PubMed] [Google Scholar]

83. Jiesong H, Megraud F. Evidence of the viability of non cultutable coccoidal forms of Helicobacter felis. Gut. 1995;37 Suppl 1:376. [Google Scholar]

84. Catrenich CE, Chestnut MH. Character and origin of vacuoles induced in mammalian cells by the cytotoxin of Helicobacter pylori. J Med Microbiol. 1992;37:389–395. [PubMed] [Google Scholar]

85. Sörberg M, Nilsson M, Hanberger H, Nilsson LE. Morphologic conversion of Helicobacter pylori from bacillary to coccoid form. Eur J Clin Microbiol Infect Dis. 1996;15:216–219. [PubMed] [Google Scholar]

86. Kusters JG, Gerrits MM, Van Strijp JA, Vandenbroucke-Grauls CM. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun. 1997;65:3672–3679. [PMC free article] [PubMed] [Google Scholar]

87. Loginov AS, Il'chenko AA, Mukamolova GV, Fedukova NG, Dudik TV, Kaprel'iants AS, Reshetniak VI. Comparative efficacy of different methods of detecting H. pylori in patients with peptic ulcer. Ross Gastroenterol Zh. 1998;3:3–11. [Google Scholar]

88. Andersen LP, Rasmussen L. Helicobacter pylori-coccoid forms and biofilm formation. FEMS Immunol Med Microbiol. 2009;56:112–115. [PubMed] [Google Scholar]

89. Bumann D, Habibi H, Kan B, Schmid M, Goosmann C, Brinkmann V, Meyer TF, Jungblut PR. Lack of stage-specific proteins in coccoid Helicobacter pylori cells. Infect Immun. 2004;72:6738–6742. [PMC free article] [PubMed] [Google Scholar]

90. Enroth H, Wreiber K, Rigo R, Risberg D, Uribe A, Engstrand L. In vitro aging of Helicobacter pylori: changes in morphology, intracellular composition and surface properties. Helicobacter. 1999;4:7–16. [PubMed] [Google Scholar]

91. Harvey P, Leach S. Analysis of coccal cell formation by Campylobacter jejuni using continuous culture techniques, and the importance of oxidative stress. J Appl Microbiol. 1998;85:398–404. [PubMed] [Google Scholar]

92. Cellini L, Allocati N, Angelucci D, Iezzi T, Di Campli E, Marzio L, Dainelli B. Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol. 1994;38:843–850. [PubMed] [Google Scholar]

93. Eaton KA, Catrenich CE, Makin KM, Krakowka S. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets. J Infect Dis. 1995;171:459–462. [PubMed] [Google Scholar]

94. Poursina F, Faghri J, Moghim S, Zarkesh-Esfahani H, Nasr-Esfahani B, Fazeli H, Hasanzadeh A, Safaei HG. Assessment of cagE and babA mRNA expression during morphological conversion of Helicobacter pylori from spiral to coccoid. Curr Microbiol. 2013;66:406–413. [PubMed] [Google Scholar]

95. Barer MR, Gribbon LT, Harwood CR, Nwoguh CE. The viable but non-culturable hypothesis and medical microbiology. Rev Med Microbiol. 1993;4:183–191. [Google Scholar]

96. Cellini L, Robuffo I, Di Campli E, Di Bartolomeo S, Taraborelli T, Dainelli B. Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? APMIS. 1998;106:571–579. [PubMed] [Google Scholar]

97. Donelli G, Matarrese P, Fiorentini C, Dainelli B, Taraborelli T, Di Campli E, Di Bartolomeo S, Cellini L. The effect of oxygen on the growth and cell morphology of Helicobacter pylori. FEMS Microbiol Lett. 1998;168:9–15. [PubMed] [Google Scholar]

98. Gribbon LT, Barer MR. Oxidative metabolism in nonculturable Helicobacter pylori and Vibrio vulnificus cells studied by substrate-enhanced tetrazolium reduction and digital image processing. Appl Environ Microbiol. 1995;61:3379–3384. [PMC free article] [PubMed] [Google Scholar]

99. Andersen LP, Dorland A, Karacan H, Colding H, Nilsson HO, Wadström T, Blom J. Possible clinical importance of the transformation of Helicobacter pylori into coccoid forms. Scand J Gastroenterol. 2000;35:897–903. [PubMed] [Google Scholar]

100. Mai U, Geis G, Leying H, Ruhl G, Opferkuch W. Dimorphism of Campylobacter pylori. Gastroduodenal pathology and Campylobacter pylori. In: Megraud F, Lamuliatte H, editors. Amsterdam: Elsevier Science; 1989. pp. 29–33. [Google Scholar]

101. Kell DB, Kenny LC. A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) 2016;3:60. [PMC free article] [PubMed] [Google Scholar]

102. Konstantinova ND, Zhukhovitskii VG, Didenko LV, Andreevskaya SG. Ultrastructural organization of Helicobacter pylori under natural conditions and during ex vivo culturing. Bull Exp Biol Med. 2001;131:299–301. [PubMed] [Google Scholar]

103. Loginov AS, Kaprel’iants AS, Reshetniak VI, Vostroknutova GN, Dudik TV, Ilchenko AA. On the possibility of genetic typing of H.pylori in gastric mucosa bioptates. Ross Gastroenterol Zh. 1999;4:5–9. [Google Scholar]

104. Dudik TV, Solov’eva NA, Zhukhovitskiĭ VG, Kirillov MIu, Kaprel’iants AS, Reshetniak VI. [Methods of Helicobacter pylori detection] Ross Gastroenterol Zh. 2001;(2):77–89. [PubMed] [Google Scholar]

105. O’Connor HJ, Kanduru C, Bhutta AS, Meehan JM, Feeley KM, Cunnane K. Effect of Helicobacter pylori eradication on peptic ulcer healing. Postgrad Med J. 1995;71:90–93. [PMC free article] [PubMed] [Google Scholar]

106. Jonaitis L, Kiudelis G, Slepavicius P, Kupcinskas L. High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol. 2016;7:181–185. [PMC free article] [PubMed] [Google Scholar]

107. Miehlke S, Lehn N, Meining A, Bästlein E, Mannes GA, Stolte M, Bayerdörffer E. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol Hepatol. 1996;8:1161–1163. [PubMed] [Google Scholar]

108. Ivashkin VT, Megro F, Lapina TL. Moscow: Publishing house “Triada-X”; 1999. Helicobacter pylori: revolution in gastroenterology; p. 255. [Google Scholar]

109. Yan TL, Hu QD, Zhang Q, Li YM, Liang TB. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment Pharmacol Ther. 2013;37:963–968. [PubMed] [Google Scholar]

110. Harris AW, Misiewicz JJ, editors . London: Blackwell Healthcare Communication; 1996. Helicobacter pylori; p. 66. [Google Scholar]

111. Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB. A bacterial cytokine. Proc Natl Acad Sci USA. 1998;95:8916–8921. [PMC free article] [PubMed] [Google Scholar]

112. Shleeva MO, Mukamolova GV, Telkov MV, Berezinskaia TL, Syroeshkin AV, Biketov SF, Kaprel’iants AS. [Formation of nonculturable Mycobacterium tuberculosis and their regeneration] Mikrobiologiia. 2003;72:76–83. [PubMed] [Google Scholar]

113. Mukamolova GV, Murzin AG, Salina EG, Demina GR, Kell DB, Kaprelyants AS, Young M. Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation. Mol Microbiol. 2006;59:84–98. [PubMed] [Google Scholar]

114. Shleeva M, Kondratieva T, Rubakova E, Vostroknutova G, Kaprelyants A, Apt A. Reactivation of dormant “non-culturable” Mycobacterium tuberculosis developed in vitro after injection in mice: both the dormancy depth and host genetics influence the outcome. Microb Pathog. 2015;78:63–66. [PubMed] [Google Scholar]

115. Votyakova TV, Kaprelyants AS, Kell DB. Influence of Viable Cells on the Resuscitation of Dormant Cells in Micrococcus luteus Cultures Held in an Extended Stationary Phase: the Population Effect. Appl Environment Microbiol. 1994;60:3284–3291. [PMC free article] [PubMed] [Google Scholar]

116. Mukamolova GV, Turapov OA, Kazarian K, Telkov M, Kaprelyants AS, Kell DB, Young M. The Rpf gene of Micrococcus luteus encodes an essential secreted growth factor. Mol Microbiol. 2002;46:611–621. [PubMed] [Google Scholar]

117. Mizoguchi H, Fujioka T, Kishi K, Nishizono A, Kodama R, Nasu M. Diversity in protein synthesis and viability of Helicobacter pylori coccoid forms in response to various stimuli. Infect Immun. 1998;66:5555–5560. [PMC free article] [PubMed] [Google Scholar]

118. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388:539–547. [PubMed] [Google Scholar]

119. Kansau I, Labigne A. Heat shock proteins of Helicobacter pylori. Aliment Pharmacol Ther. 1996;10 Suppl 1:51–56. [PubMed] [Google Scholar]

How long does it take for H. pylori to go away?

Most people are cured after finishing two weeks of medicine. Some people need to take another two weeks of medicine. It is important to finish all of the medicine to ensure that the bacteria are killed. Guidelines recommend that all patients treated for H.

What are the symptoms of H. pylori infection?

When signs or symptoms do occur with H. pylori infection, they are typically related to gastritis or a peptic ulcer and may include:.
An ache or burning pain in your stomach (abdomen).
Stomach pain that may be worse when your stomach is empty..
Nausea..
Loss of appetite..
Frequent burping..
Bloating..
Unintentional weight loss..

What is H. pylori and how is it treated?

H. pylori infections are usually treated with at least two different antibiotics at once. This helps prevent the bacteria from developing a resistance to one particular antibiotic. Treatment may also include medications to help your stomach heal, including: Proton pump inhibitors (PPIs).

Can H. pylori go away on its own?

You can cure H. pylori infection only if you take the medicines just the way your doctor tells you. If you forget to take some of your medicines or stop taking them because of side effects, the infection will not be cured. You may get another ulcer in the future.